From January 1, 2023 to March 22, 2023, the company has repurchased 331,100 shares, representing 0.9% for ¥1,122.92 million. With this, the company has completed the repurchase of 1,036,200 shares, representing 2.78% for ¥3,499.72 million under the buyback announced on August 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,365 JPY | -0.15% |
|
+0.45% | +2.91% |
25/04 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
21/03 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.91% | 757M | |
+63.14% | 856B | |
+39.55% | 631B | |
-4.73% | 359B | |
+17.42% | 325B | |
+8.46% | 297B | |
+5.56% | 234B | |
+16.44% | 226B | |
+14.03% | 177B | |
+1.29% | 165B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 1, 2022.